Trademark Details For XTANDI (Serial Number 79110148)

  •  Home
  •  Print
XTANDI
1
1
1
0
Basic Information
Serial Number  United States - USPTO 79110148
Registration Number 4181564
Mark
XTANDI
Filing Date Dec-27-2011
Status
Registered  
SECTION 71 A.. (706)
SECTION 71 ACCEPTED
Attorney Name
TTAB
0


  • ASTELLAS PHARMA, INC.

  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameChristopher Bolinger Astellas Pharma Inc.
Address2375 Waterview Drive Trademarks Department Northbrook, IL 60602 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Apr-06-2012SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM
Apr-10-2012LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Apr-11-2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Apr-11-2012ASSIGNED TO EXAMINER   DOCKD
Apr-11-2012APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-17-2012APPLICATION FILING RECEIPT MAILED   MAFRO
Apr-25-2012NOTICE OF PUBLICATION   NPUBO
May-15-2012PUBLISHED FOR OPPOSITION   PUBOA
Jul-31-2012REGISTERED-PRINCIPAL REGISTER   R.PRA
Aug-30-2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB   GPARP
Aug-31-2012FINAL DISPOSITION PROCESSED   FIMPP
Aug-31-2012FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Oct-07-2012NOTIFICATION PROCESSED BY IB   GPNXP
May-31-2013CHANGE OF NAME/ADDRESS REC'D FROM IB   ADCHM
Jul-13-2013CORRECTION TRANSACTION RECEIVED FROM IB   CRCVM
Jul-16-2013CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED   CORRI
Feb-16-2018TEAS SECTION 71 & 15 RECEIVED   ES75I
Mar-06-2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Mar-16-2018REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.   C75AO
Mar-16-2018NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED   NA75O
Dec-10-2019CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Jan-08-2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED   CORV1
Oct-23-2020NEW REPRESENTATIVE AT IB RECEIVED   NREPP
Jan-13-2022INTERNATIONAL REGISTRATION RENEWED   RNWLP
Apr-23-2022NEW REPRESENTATIVE AT IB RECEIVED   NREPP
Jun-03-2022TEAS CHANGE OF OWNER ADDRESS RECEIVED   COARI
Jun-03-2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jun-03-2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Jun-03-2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS   ECDRI
Jun-03-2022TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jun-03-2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED   CHANI
Jun-25-2022NEW REPRESENTATIVE AT IB RECEIVED   NREPP
Jul-07-2022TEAS SECTION 71 RECEIVED   ES71I
Jan-17-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-17-2023REGISTERED-SEC.71 ACCEPTED   71AGO
Jan-17-2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED   NA71E
Jul-09-2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jul-09-2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Jul-09-2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS   ECDRI
Jul-09-2024TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jul-09-2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS   EWAFI
Apr-14-2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Apr-14-2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Apr-14-2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS   ECDRI
Apr-14-2025TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Apr-14-2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS   EWAFI